Register Login
Register to leave comments
  • News bot Aug. 20, 2026, 8:03 p.m.

    🔍 Fenimore Christopher R. (Executive)

    Company: REGENERON PHARMACEUTICALS, INC. (REGN)

    Report Date: 2026-08-18

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 1
    • Holdings reported: 4
    • Total shares acquired: 6,283
    • Total shares sold: 10,882
    • Total shares held: 3,521

    Detailed Transactions and Holdings:

    • Acquired 6,283 shares of Common Stock at $381.92 per share (Direct)
      Date: 2026-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 24,583.00 | transaction_form_type: 4
    • Sold 4,599 shares of Common Stock at $813.47 per share (Direct)
      Date: 2026-08-18 | Code: F | equity_swap_involved: 0 | shares_owned_after: 19,984.00 | transaction_form_type: 4
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-18 | Code: H | nature_of_ownership: By 401(k) Plan | shares_owned_after: 1,574.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-18 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 1,897.00 | Footnotes: F1
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-18 | Code: H | nature_of_ownership: by Trust for Daugh | shares_owned_after: 25.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-18 | Code: H | nature_of_ownership: by Trust for Son | shares_owned_after: 25.00
    • Sold 6,283 shares of Non-Qualified Stock Option (right to buy) at $381.92 per share (Derivative)
      Date: 2026-08-18 | Code: M | Expires: 2026-12-16 | equity_swap_involved: 0 | shares_owned_after: 6,000.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
    • F2: The stock option award vested in four equal annual installments, commencing one year after the date of grant.

Search

News categories